Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride 1mg helps reverse hair miniaturization in men and postmenopausal women.

A new diagnostic tool for Vulvovaginal Lichen Planus is highly accurate, and updated treatments for various skin conditions, including melanoma and Hidradenitis Suppurativa, were discussed.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

A man with KID syndrome developed a rare cancer in a long-term skin infection.

FFA in young women is often missed, and no single treatment works best.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

A 46-year-old man showed symptoms of a rare condition usually seen in postmenopausal women, highlighting the need for dentist-dermatologist collaboration.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Zinc deficiency in children can cause skin issues and can be serious if not diagnosed and treated properly.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Some nutrients and antioxidants may improve skin and hair health, but more research is needed to confirm these benefits.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

Nanoemulgel is a better way to deliver drugs through the skin for various conditions.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.